Cardiovascular aging: the unveiled enigma from bench to bedside

Area of Science:

• Gerontology
• Cardiology
• Pathophysiology

Background:

• Global population is aging, increasing the number of elderly individuals requiring specialized medical attention.
• Cardiovascular risk factors, aging itself, and comorbidities significantly contribute to heart failure development in the elderly.
• Heart failure in older adults presents in two main forms: with reduced ejection fraction and with preserved ejection fraction.

Purpose of the Study:

• To investigate the primary pathways involved in the development of aging cardiomyopathy.
• To dissect the pathophysiological processes underlying age-related heart dysfunction.
• To bridge the understanding of molecular mechanisms (bench) with the clinical presentation (bedside) of aging cardiomyopathy.

Main Methods:

• Literature review focusing on aging, cardiovascular risk factors, and heart failure.
• Analysis of pathophysiological mechanisms contributing to age-related cardiac changes.
• Synthesis of current research on bench-to-bedside translation in aging cardiomyopathy.

Main Results:

• Aging involves specific molecular and cellular changes that impair cardiac function.
• The interplay of risk factors and comorbidities exacerbates age-related cardiac decline.
• Understanding these mechanisms is crucial for developing targeted therapies.

Conclusions:

• Aging cardiomyopathy is a complex condition driven by multiple factors.
• Targeted therapeutic strategies are needed to address the unique needs of elderly patients with heart failure.
• Further research is essential to fully elucidate the bench-to-bedside relationship in aging cardiomyopathy.